CTA
AHCO icon

Carillon Tower Advisers’s AdaptHealth AHCO Stock Holding History

Carillon Tower Advisers’s Portfolio AHCO Stock Details AHCO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		$7.72M Sell
205,600
-9,400
-4% -$291K 0.05% 353
2020
Q3 		$4.69M Buy
+215,000
New +$4.51M 0.06% 339

Other funds holding AHCO

OCA
OEP Capital Advisors New York $170M AUM 10.5% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SAM
Silvercrest Asset Management New York $15.3B AUM 40.56% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $42.4B AUM 181.11% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
MS
Maven Securities St Helier, Jersey $5.06B AUM 59.27% 1-Year Est. Return

Carillon Tower Advisers's AHCO Position: Q4 2020 in Review

Carillon Tower Advisers reduced its AdaptHealth (AHCO) stake by 4.4% in Q4 2020, selling an estimated $291K and leaving 205,600 shares worth $7.72M. The position accounts for 0.05% of the portfolio, ranked #353.

Carillon Tower Advisers first reported a position in AHCO in Q3 2020 and has held it in 2 quarters since. 134 funds tracked by Wall St. Rank hold AHCO as of Q4 2020.

  • Carillon Tower Advisers held 205,600 shares of AdaptHealth worth $7.72M as of Q4 2020.
  • Carillon Tower Advisers sold 9,400 AdaptHealth shares in Q4 2020, an estimated $291K.
  • AdaptHealth made up 0.05% of Carillon Tower Advisers's portfolio in Q4 2020, its #353 holding.
  • Carillon Tower Advisers first reported a position in AdaptHealth in Q3 2020 and has held it in 2 quarters since.
  • 134 funds tracked by Wall St. Rank held AdaptHealth as of Q4 2020.

Based on Carillon Tower Advisers's 13F filing for Q4 2020, filed 12 Feb 2021.